Overall survival and event-free survival for patients from the whole series. (A) Overall survival for the whole series. (B) Event-free survival for the whole series. (C) Overall survival according to the consolidation and maintenance (Cons+Maint) therapy (green line) vs allogeneic hematopoietic stem cell transplantation (allo-HSCT) (blue line) by intention-to treat.